Catherine Mills

4PUBLICATIONS
28CO-AUTHORS
Molecular targetsBiomolecular modelling and designHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 27, 2023
Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma.

Catherine M Mills, Thomas Z Benton, Ivett Piña

|Sep 15, 2022
New Transmission-Selective Antimalarial Agents through Hit-to-Lead Optimization of 2-([1,1'-Biphenyl]-4-carboxamido)benzoic Acid Derivatives.

Janette Reader, Daniel F L Opperman, Mariëtte E van der Watt

|Jun 24, 2022
Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs.

Tyler C Beck, Kendra Springs, Jordan E Morningstar

|Jan 10, 2020
Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β.

Alessandra Metelli, Bill X Wu, Brian Riesenberg

Pageof 1